HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osvaldo N Oliveira Selected Research

Osvaldo N Oliveira Research Topics

Disease

17Neoplasms (Cancer)
05/2024 - 11/2015
6Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 11/2015
3Breast Neoplasms (Breast Cancer)
03/2022 - 06/2015
2Phototoxic Dermatitis (Phototoxicity)
04/2024 - 10/2020
2Dehydration (Water Stress)
10/2022 - 08/2015
2COVID-19
06/2022 - 03/2022
2Neglected Diseases
01/2022 - 12/2021
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 12/2019
2Infections
01/2021 - 10/2017
2Wounds and Injuries (Trauma)
10/2020 - 01/2018
2Carcinoma (Carcinomatosis)
10/2020 - 03/2016
2Rupture
09/2013 - 03/2005
2African Trypanosomiasis (Nagana)
07/2011 - 12/2009
1Colorectal Neoplasms (Colorectal Cancer)
04/2024
1Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1Mastitis
04/2023
1Adenocarcinoma of Lung
03/2022
1Hyperthermia
03/2022
1Neuromyelitis Optica (Devic's Disease)
01/2022
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Inflammation (Inflammations)
04/2021
1Dengue (Dengue Fever)
01/2021
1Carcinogenesis
09/2020
1Multiple Sclerosis
01/2020
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2019
1Hemolysis
01/2019
1Rare Diseases (Rare Disease)
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2018
1Papillomavirus Infections
10/2018
1Lung Diseases (Lung Disease)
10/2017
1Pneumonia (Pneumonitis)
10/2017
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2017

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
08/2022 - 06/2015
7AntigensIBA
12/2021 - 03/2007
6GoldIBA
04/2024 - 02/2012
5Peptides (Polypeptides)IBA
04/2021 - 12/2009
4AntibodiesIBA
06/2022 - 03/2007
4Proteins (Proteins, Gene)FDA Link
03/2022 - 06/2013
3CholesterolIBA
10/2022 - 10/2014
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2022 - 03/2005
2benzonidazole (benznidazole)IBA
01/2022 - 12/2021
2Praziquantel (Biltricide)FDA Link
01/2022 - 12/2021
2ArtesunateIBA
01/2022 - 12/2021
2Mefloquine (Lariam)FDA LinkGeneric
01/2022 - 12/2021
2AutoantibodiesIBA
01/2022 - 01/2019
2CarbohydratesIBA
12/2021 - 01/2020
2Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2020
2PolymersIBA
10/2020 - 02/2012
2Immunoglobulin G (IgG)IBA
01/2019 - 03/2007
2BuffersIBA
10/2018 - 08/2017
2Carbon Nanotubes (Carbon Nanotube)IBA
10/2017 - 08/2017
2Liposomes (Liposome)IBA
09/2013 - 03/2007
1RutheniumIBA
05/2024
1Tolonium ChlorideFDA Link
04/2024
11-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2024
1LipidsIBA
04/2024
1Hormones (Hormone)IBA
11/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1Aquaporin 4IBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1Photosensitizing Agents (Photosensitizers)IBA
07/2021
1C-Reactive ProteinIBA
04/2021
1GemcitabineFDA Link
12/2020
1NucleosidesIBA
12/2020
1AntimetabolitesIBA
12/2020
1pyrimidineIBA
12/2020
11,2-oleoylphosphatidylcholine (DOPC)IBA
10/2020
1PhosphatidylserinesIBA
09/2020
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2020
1AntioxidantsIBA
09/2020
1dipalmitoylphosphatidylserineIBA
09/2020
1Phosphatidylcholines (Phosphatidylcholine)IBA
09/2020
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2020
1micaIBA
01/2020
1Hyaluronic Acid (Hyaluronan)IBA
01/2020
1Myelin Basic ProteinIBA
01/2020
1ChitosanIBA
01/2020
1SootIBA
01/2020
1PolyelectrolytesIBA
01/2020
1myelin basic protein 85-99IBA
01/2020
1Polysaccharides (Glycans)IBA
01/2020
1Fibroins (Fibroin)IBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Monoclonal AntibodiesIBA
01/2019
1Biocompatible Materials (Biomaterials)IBA
01/2018
1Azo CompoundsIBA
01/2018
1EnzymesIBA
01/2018
1polyallylamineIBA
10/2017
1methylallyl trisulfide (MATS)IBA
10/2017
1nylon 6 (Perlon)IBA
10/2017
1Levofloxacin (Levaquin)FDA Link
10/2017
1Hemolysin Proteins (Hemolysins)IBA
10/2017

Therapy/Procedure

5Electrodes (Electrode)
01/2020 - 03/2007
2Electronic Nose
04/2023 - 06/2022
2Therapeutics
10/2020 - 01/2015
1Photochemotherapy (Photodynamic Therapy)
04/2024
1Phototherapy (Light Therapy)
04/2024
1Photothermal Therapy
03/2022
1Artificial Skin
10/2020
1Lab-On-A-Chip Devices
10/2018